Filing Details
- Accession Number:
- 0001209191-16-089766
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-06 16:04:34
- Reporting Period:
- 2016-01-01
- Filing Date:
- 2016-01-06
- Accepted Time:
- 2016-01-06 16:04:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1517022 | Akebia Therapeutics Inc. | AKBA | Pharmaceutical Preparations (2834) | 208756903 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1602396 | R. Nicole Hadas | C/O Akebia Therapeutics, Inc. 245 First Street, Suite 1100 Cambridge MA 02142 | Svp, General Counsel, Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-01-04 | 1,811 | $12.28 | 64,584 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- 72,623 shares of restricted stock (as adjusted from 41,499 shares prior to the 1.75-for-1 stock split effected on March 6, 2014) were awarded on December 23, 2013. Twenty-five percent of the shares vested on December 2, 2014. The remaining shares vest in equal quarterly installments over the following three years until fully vested.
- Shares sold by reporting person to pay taxes in connection with the vesting of restricted stock pursuant to the December 23, 2013 award described in footnote 1.
- The total amount of beneficial securities owned includes 1,135 shares of stock purchased on December 31, 2015 at $8.27 per share in connection with the Issuer's Employee Stock Purchase Plan.
Billionaire Hedge Funds
